JPRN-UMIN000000650已完成2 期
Efficacy of sivelestat sodium administration in perioperative care of abdominal aortic aneurysm with pulmonary function disorder - sivelestat sodium and abdominal aortic aneurysm
Keio University, School of Medicine Department of Surgery0 个研究点目标入组 40 人开始时间: 2007年5月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Cases matching following conditions are excluded from the trial. (1)Patients allergic to the components of sivelestat sodium. (2)Patients who are pregnant, have a possibility of pregnancy, and breast-feeding. (3)Patients with evidence of high left atrium pressure. (4)Cases that are considered not eligible for the trial by the doctor in charge. (5)Patients without pulmonary function disorder, meaning patients with the P/F ratio of more than 300 and the chest X-ray that does not show bilateral infiltration shadow during the operation.
研究者
相似试验
已完成
1 期
A pilot study of Elaspol (Sivelestat Sodium) for neuromyelitis opticaneuromyelitis opticaJPRN-UMIN000010094Tohoku University Hospital10
已完成
3 期
Efficacy and Safety of Sivelestat in Preventing Postoperative Acute Lung Injury or Acute Respiratory Distress Syndrome After Cardiac SurgeryCardiac DiseaseNCT06276569The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School382
已完成
不适用
Sivelestat Sodium Hydrate Treatment for Patients with Kawasaki Disease refractory to initial intravenous immunoglobulin therapyKawasaki DiseaseJPRN-UMIN000013018Department of Pediatrics, Chiba University Hospital45
未知
4 期
Post marketing study of sivelestat sodium hydrate for acute lung injury associated with systemic inflammatory response syndromeAcute lung injury (ALI) associated with systemic inflammatory response syndrome (SIRS)JPRN-jRCT1080220086ONO PHARMACEUTICAL CO.,LTD.
已完成
4 期
Study of Sivelestat Sodium Hydrate in Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS) in JapanSystemic Inflammatory Response SyndromeAcute Lung InjuryNCT00219375Ono Pharmaceutical Co. Ltd649